Mehmet Tughan Kiziltug is an accomplished researcher in molecular medicine and gene therapy, with a robust academic background and extensive experience in genetic disease research. Currently pursuing a second Ph.D. in Genomic and Molecular Medicine at Ludwig-Maximilians-Universität (LMU) Munich, Germany (2020–present, expected graduation October 2026), Mehmet specializes in gene therapy using induced pluripotent stem cells (iPSCs) and hematopoietic stem cells (HSCs), focusing on adeno-associated virus (AAV) and lentiviral vector systems. His research emphasizes capsid engineering for AAV vectors and next-generation targeted pseudotyped lentiviruses to enhance the precision and efficacy of gene delivery for therapeutic applications.
Dr. von Hauner Children's Hospital, Medical Center of the LMU University
Munich, Bavaria, Germany
CCRC Hauner
Undergraduate and Graduate Outstanding Achievement Scholarship
Turkish Education Foundation
National PhD Scholarship
Scientific and Technological Research Council of Türkiye (TÜBİTAK)
Priority Area Overseas Doctoral Scholarship
Ministry of National Education, Türkiye